A detailed history of Flat Footed LLC transactions in Grifols Sa stock. As of the latest transaction made, Flat Footed LLC holds 1,803,600 shares of GRFS stock, worth $15.1 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
1,803,600
Previous 7,036,880 74.37%
Holding current value
$15.1 Million
Previous $47 Million 75.83%
% of portfolio
1.12%
Previous 10.42%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.27 - $7.7 $12.2 Million - $14.9 Million
1,939,541 Added 27.56%
8,976,421 $56.6 Million
Q1 2024

May 15, 2024

SELL
$5.47 - $11.38 $1.76 Million - $3.66 Million
-321,899 Reduced 4.37%
7,036,880 $47 Million
Q4 2023

Feb 14, 2024

SELL
$7.71 - $11.56 $15 Million - $22.4 Million
-1,941,520 Reduced 20.88%
7,358,779 $85.1 Million
Q3 2023

Nov 14, 2023

BUY
$8.91 - $10.91 $9.35 Million - $11.4 Million
1,049,155 Added 12.72%
9,300,299 $85 Million
Q2 2023

Aug 14, 2023

SELL
$7.14 - $9.29 $2.94 Million - $3.83 Million
-412,104 Reduced 4.76%
8,251,144 $75.6 Million
Q1 2023

May 15, 2023

BUY
$6.65 - $10.69 $4.82 Million - $7.75 Million
724,514 Added 9.13%
8,663,248 $63.8 Million
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.53 $13.9 Million - $19.9 Million
2,338,553 Added 41.76%
7,938,734 $67.5 Million
Q3 2022

Nov 14, 2022

BUY
$5.95 - $14.3 $27.7 Million - $66.7 Million
4,662,971 Added 497.54%
5,600,181 $34.5 Million
Q2 2022

Aug 15, 2022

SELL
$10.6 - $13.28 $1.11 Million - $1.39 Million
-104,504 Reduced 10.03%
937,210 $11.1 Million
Q1 2022

May 16, 2022

SELL
$10.37 - $12.73 $1.19 Million - $1.46 Million
-114,447 Reduced 9.9%
1,041,714 $12.2 Million
Q4 2021

Feb 14, 2022

BUY
$10.21 - $15.27 $11.8 Million - $17.7 Million
1,156,161 New
1,156,161 $13 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.67B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Flat Footed LLC Portfolio

Follow Flat Footed LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flat Footed LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flat Footed LLC with notifications on news.